mRNA |
BRD-K03536150 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0001 |
mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0001 |
mRNA |
piperlongumine |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0002 |
mRNA |
BRD-K34222889 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0002 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0003 |
mRNA |
pac-1 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0003 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0003 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0005 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0005 |
mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0005 |